Mark Grayson

GHP Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news for the funding of neglected diseases in the developing world. In a press release issued by Policy Cures, an ind... Read >

Global Health Progress Encourages Global Partnerships on Access to Health Care

Starting this month, members of Congress will be looking closely at U.S. spending as they work with the White House to build the 2012 budget. One area that has come under increased scrutiny is U.S. spending on global health programs. Several groups las... Read >

GHP Amplifies New Report That Stresses Importance of Drug Patents

“There is a public health crisis in the least developed countries. It is a crisis made by humans and solvable only by humans. There is urgency for governments, businesses, NGOs and academia to collaborate in dealing with this most urgent of problems," dec... Read >

GHP Fact Sheet Reveals Mexico’s Investment in Biopharmaceutical Sector

A recent Global Health Progress fact sheet highlights how Mexico’s investment in its biopharmaceutical sector has spurred economic growth, fostered global competitiveness, reduced the health and economic burden of disease on local citizens, and improved a... Read >

Response Papers Call India’s Compulsory Licensing “Counter-Productive”

Recently, The Department of Industrial Policy and Promotion (DIPP) distributed a discussion paper speculating how India’s compulsory licensing policy impacts the market-availability of low-price life saving drugs. Upon completion of this paper, DIPP reque... Read >

GHP Fact Sheet Projects China to Become Major Biopharmaceutical Player

Data revealed in Global Health Progress’ (GHP) new fact sheet shows that China is projected to become one of the world’s major biopharmaceutical players, along with the U.S., Europe, and Japan, in the next fifteen years. This projection is based on China’... Read >

GHP Fact Sheet Highlights Russia’s Commitment to Biotechnology Sector

Global Health Progress (GHP) released a new fact sheet highlighting Russia’s commitment to expanding and promoting its biotechnology sector. Although the biopharmaceutical sector in Russia is less developed than other markets, the sector is making progre... Read >

Global Health Progress highlights growth of Turkey’s biotechnology sector

A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a positi... Read >

Global Health Progress agrees criticizing "Big Pharma" is not the answer

In recent commentary in the Wall Street Journal, Alec van Gelder, Project Director at the International Policy Network wrote that strong intellectual property rights are critical to strengthening Africa's health care system. He criticized statements by t... Read >

GHP Supports New Drug Development to Combat “Untouchable” Diseases

Scientists from government, industry, and academia presenting at the 240th National Meeting of the American Chemical Society released a new report highlighting advances in creating the next generation of medicines for treating cancer, diabetes, and other ... Read >

MMV Joins The Pool for Open Innovation against Neglected Tropical Diseases

Global Health Progress (GHP) is pleased to highlight the announcement that the not-for-profit public-private partnership Medicines for Malaria Venture (MMV) became the first product development partnership (PDP) to contribute intellectual property to The ... Read >

GHP Stresses Importance of Product Development Partnerships

Helen Coster's recent commentary in her new Forbes blog Good Work addresses the issue of how product development partnerships (PDPs) can develop and improve treatments for neglected diseases like malaria, leishmaniasis, and Chagas disease. Coster note... Read >

Partnerships Ensure Continued Progress on Malaria Vaccine

During the recent African Union summit, the African Leaders Malaria Alliance (ALMA) gathered to discuss how to combat the threat of malaria in the continent. Inspired by this meeting, Madiké Seye, Vice-President for Africa - GlaxoSmithKline wrote a gues... Read >

Global Health Progress' New Report Features Solutions to Improve Access to Healthcare in India

Global Health Progress' recently released report, Innovative Solutions to Improving Health in India, summarizes how the organization is committed to building sustainable, innovative solutions to secure access to healthcare for all Indian communities. T... Read >

IPN Discusses Unitaid Pool for Pharmaceutical Patents

International Policy Network (IPN), a nongovernmental educational organization focused on highlighting the role of free society institutions in social and economic development, recently discussed some of the limitations of the Unitaid pool for pharmaceuti... Read >